APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Hyaluronic Acid and Botulinum Toxin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Injectable Hyaluronic Acid and Botulinum Toxin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchInjectable Hyaluronic Acid and Botulinum Toxin Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Hyaluronic Acid and Botulinum Toxin Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Injectable Hyaluronic Acid and Botulinum Toxin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin include Haohai Biological, AbbVie, US World Meds, Teoxane, Suneva Medical, Sinclair, SciVision Biotech, Prollenium and Merz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Hyaluronic Acid and Botulinum Toxin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Hyaluronic Acid and Botulinum Toxin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Hyaluronic Acid and Botulinum Toxin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Hyaluronic Acid and Botulinum Toxin market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Company

Haohai Biological

AbbVie

US World Meds

Teoxane

Suneva Medical

Sinclair

SciVision Biotech

Prollenium

Merz

Medytox

LIBP

LG Life Sciences

JETEMA

Ipsen

Hugel

Galderma

Elravie (Humedix)

Daewoong

Croma-Pharma

Cleviel (Pharma Research Products)

CG Bio

Caregen

Bohus BioTech

Bloomage Bio

Beijing IMEIK

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Type

Injectable Hyaluronic Acid

Botulinum Toxin

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Application

Cosmetic

Medical

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Hyaluronic Acid and Botulinum Toxin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Hyaluronic Acid and Botulinum Toxin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Hyaluronic Acid and Botulinum Toxin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Hyaluronic Acid and Botulinum Toxin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Hyaluronic Acid and Botulinum Toxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Injectable Hyaluronic Acid and Botulinum Toxin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Injectable Hyaluronic Acid and Botulinum Toxin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends Table 2. Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers Table 3. Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges Table 4. Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints Table 5. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Manufacturers Table 9. Global Injectable Hyaluronic Acid and Botulinum Toxin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers, Product Type & Application Table 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Hyaluronic Acid and Botulinum Toxin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectable Hyaluronic Acid Table 17. Major Manufacturers of Botulinum Toxin Table 18. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 20. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 21. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2021-2026) Table 22. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2027-2032) Table 23. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2026) & (k units) Table 25. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2027-2032) & (k units) Table 26. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2021-2026) Table 27. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cosmetic Table 29. Major Manufacturers of Medical Table 30. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 32. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 33. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2021-2026) Table 34. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2027-2032) Table 35. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2026) & (k units) Table 37. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2027-2032) & (k units) Table 38. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2021-2026) Table 39. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2027-2032) Table 40. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026) & (k units) Table 42. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2021-2026) Table 43. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 47. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 48. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 50. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2027-2032) & (k units) Table 57. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2021-2026) Table 61. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2027-2032) Table 62. Haohai Biological Company Information Table 63. Haohai Biological Business Overview Table 64. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 66. Haohai Biological Recent Development Table 67. AbbVie Company Information Table 68. AbbVie Business Overview Table 69. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 71. AbbVie Recent Development Table 72. US World Meds Company Information Table 73. US World Meds Business Overview Table 74. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 76. US World Meds Recent Development Table 77. Teoxane Company Information Table 78. Teoxane Business Overview Table 79. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 81. Teoxane Recent Development Table 82. Suneva Medical Company Information Table 83. Suneva Medical Business Overview Table 84. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 86. Suneva Medical Recent Development Table 87. Sinclair Company Information Table 88. Sinclair Business Overview Table 89. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 91. Sinclair Recent Development Table 92. SciVision Biotech Company Information Table 93. SciVision Biotech Business Overview Table 94. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 96. SciVision Biotech Recent Development Table 97. Prollenium Company Information Table 98. Prollenium Business Overview Table 99. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 101. Prollenium Recent Development Table 102. Merz Company Information Table 103. Merz Business Overview Table 104. Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 106. Merz Recent Development Table 107. Medytox Company Information Table 108. Medytox Business Overview Table 109. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 111. Medytox Recent Development Table 112. LIBP Company Information Table 113. LIBP Business Overview Table 114. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 116. LIBP Recent Development Table 117. LG Life Sciences Company Information Table 118. LG Life Sciences Business Overview Table 119. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 121. LG Life Sciences Recent Development Table 122. JETEMA Company Information Table 123. JETEMA Business Overview Table 124. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 126. JETEMA Recent Development Table 127. Ipsen Company Information Table 128. Ipsen Business Overview Table 129. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 131. Ipsen Recent Development Table 132. Hugel Company Information Table 133. Hugel Business Overview Table 134. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 136. Hugel Recent Development Table 137. Galderma Company Information Table 138. Galderma Business Overview Table 139. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 141. Galderma Recent Development Table 142. Elravie (Humedix) Company Information Table 143. Elravie (Humedix) Business Overview Table 144. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 146. Elravie (Humedix) Recent Development Table 147. Daewoong Company Information Table 148. Daewoong Business Overview Table 149. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 151. Daewoong Recent Development Table 152. Croma-Pharma Company Information Table 153. Croma-Pharma Business Overview Table 154. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 156. Croma-Pharma Recent Development Table 157. Cleviel (Pharma Research Products) Company Information Table 158. Cleviel (Pharma Research Products) Business Overview Table 159. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 161. Cleviel (Pharma Research Products) Recent Development Table 162. CG Bio Company Information Table 163. CG Bio Business Overview Table 164. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 166. CG Bio Recent Development Table 167. Caregen Company Information Table 168. Caregen Business Overview Table 169. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 171. Caregen Recent Development Table 172. Bohus BioTech Company Information Table 173. Bohus BioTech Business Overview Table 174. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 176. Bohus BioTech Recent Development Table 177. Bloomage Bio Company Information Table 178. Bloomage Bio Business Overview Table 179. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 180. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 181. Bloomage Bio Recent Development Table 182. Beijing IMEIK Company Information Table 183. Beijing IMEIK Business Overview Table 184. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 185. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 186. Beijing IMEIK Recent Development Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Injectable Hyaluronic Acid and Botulinum Toxin Distributors List Table 190. Injectable Hyaluronic Acid and Botulinum Toxin Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Injectable Hyaluronic Acid and Botulinum Toxin Product Image Figure 2. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (2021-2032) & (k units) Figure 5. Global Injectable Hyaluronic Acid and Botulinum Toxin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Injectable Hyaluronic Acid and Botulinum Toxin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectable Hyaluronic Acid Image Figure 9. Botulinum Toxin Image Figure 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2021-2032) Figure 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2021-2032) Figure 16. Cosmetic Image Figure 17. Medical Image Figure 18. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2021-2032) Figure 21. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2021-2032) Figure 24. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2032) Figure 26. U.S. Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2032) Figure 31. Germany Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2032) Figure 38. China Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2032) Figure 46. Brazil Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Injectable Hyaluronic Acid and Botulinum Toxin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Figure 57. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Figure 59. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Injectable Hyaluronic Acid and Botulinum Toxin Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Hyaluronic Acid
  • Botulinum Toxin
Applications
  • Cosmetic
  • Medical
Companies covered
  • Haohai Biological
  • AbbVie
  • US World Meds
  • Teoxane
  • Suneva Medical
  • Sinclair
  • SciVision Biotech
  • Prollenium
  • Merz
  • Medytox
  • LIBP
  • LG Life Sciences
  • JETEMA
  • Ipsen
  • Hugel
  • Galderma
  • Elravie (Humedix)
  • Daewoong
  • Croma-Pharma
  • Cleviel (Pharma Research Products)
  • CG Bio
  • Caregen
  • Bohus BioTech
  • Bloomage Bio
  • Beijing IMEIK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Dynamics
  1. 2.1 Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends
  2. 2.2 Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers
  3. 2.3 Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges
  4. 2.4 Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints
3 Injectable Hyaluronic Acid and Botulinum Toxin Market by Manufacturers
  1. 3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Hyaluronic Acid and Botulinum Toxin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers, Product Type & Application
  7. 3.7 Global Injectable Hyaluronic Acid and Botulinum Toxin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Hyaluronic Acid and Botulinum Toxin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Hyaluronic Acid and Botulinum Toxin Tier 1, Tier 2, and Tier 3
4 Injectable Hyaluronic Acid and Botulinum Toxin Market by Type
  1. 4.1 Injectable Hyaluronic Acid and Botulinum Toxin Type Introduction
  2. 4.1.1 Injectable Hyaluronic Acid
  3. 4.1.2 Botulinum Toxin
  4. 4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type
  5. 4.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2032)
  7. 4.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type
  9. 4.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2021-2032)
  11. 4.3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2021-2032)
5 Injectable Hyaluronic Acid and Botulinum Toxin Market by Application
  1. 5.1 Injectable Hyaluronic Acid and Botulinum Toxin Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Medical
  4. 5.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application
  5. 5.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2032)
  7. 5.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application
  9. 5.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2021-2032)
  11. 5.3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2021-2032)
6 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region
  1. 6.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026)
  4. 6.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region
  1. 7.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region
  2. 7.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2021-2026)
  4. 7.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2027-2032)
  5. 7.1.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032)
  8. 7.2.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032)
  11. 7.3.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Haohai Biological
  2. 8.1.1 Haohai Biological Company Information
  3. 8.1.2 Haohai Biological Business Overview
  4. 8.1.3 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  6. 8.1.5 Haohai Biological Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 US World Meds
  14. 8.3.1 US World Meds Company Information
  15. 8.3.2 US World Meds Business Overview
  16. 8.3.3 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  18. 8.3.5 US World Meds Recent Developments
  19. 8.4 Teoxane
  20. 8.4.1 Teoxane Company Information
  21. 8.4.2 Teoxane Business Overview
  22. 8.4.3 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  24. 8.4.5 Teoxane Recent Developments
  25. 8.5 Suneva Medical
  26. 8.5.1 Suneva Medical Company Information
  27. 8.5.2 Suneva Medical Business Overview
  28. 8.5.3 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  30. 8.5.5 Suneva Medical Recent Developments
  31. 8.6 Sinclair
  32. 8.6.1 Sinclair Company Information
  33. 8.6.2 Sinclair Business Overview
  34. 8.6.3 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  36. 8.6.5 Sinclair Recent Developments
  37. 8.7 SciVision Biotech
  38. 8.7.1 SciVision Biotech Company Information
  39. 8.7.2 SciVision Biotech Business Overview
  40. 8.7.3 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  42. 8.7.5 SciVision Biotech Recent Developments
  43. 8.8 Prollenium
  44. 8.8.1 Prollenium Company Information
  45. 8.8.2 Prollenium Business Overview
  46. 8.8.3 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  48. 8.8.5 Prollenium Recent Developments
  49. 8.9 Merz
  50. 8.9.1 Merz Company Information
  51. 8.9.2 Merz Business Overview
  52. 8.9.3 Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  54. 8.9.5 Merz Recent Developments
  55. 8.10 Medytox
  56. 8.10.1 Medytox Company Information
  57. 8.10.2 Medytox Business Overview
  58. 8.10.3 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  60. 8.10.5 Medytox Recent Developments
  61. 8.11 LIBP
  62. 8.11.1 LIBP Company Information
  63. 8.11.2 LIBP Business Overview
  64. 8.11.3 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  66. 8.11.5 LIBP Recent Developments
  67. 8.12 LG Life Sciences
  68. 8.12.1 LG Life Sciences Company Information
  69. 8.12.2 LG Life Sciences Business Overview
  70. 8.12.3 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  72. 8.12.5 LG Life Sciences Recent Developments
  73. 8.13 JETEMA
  74. 8.13.1 JETEMA Company Information
  75. 8.13.2 JETEMA Business Overview
  76. 8.13.3 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  78. 8.13.5 JETEMA Recent Developments
  79. 8.14 Ipsen
  80. 8.14.1 Ipsen Company Information
  81. 8.14.2 Ipsen Business Overview
  82. 8.14.3 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  84. 8.14.5 Ipsen Recent Developments
  85. 8.15 Hugel
  86. 8.15.1 Hugel Company Information
  87. 8.15.2 Hugel Business Overview
  88. 8.15.3 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  90. 8.15.5 Hugel Recent Developments
  91. 8.16 Galderma
  92. 8.16.1 Galderma Company Information
  93. 8.16.2 Galderma Business Overview
  94. 8.16.3 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  96. 8.16.5 Galderma Recent Developments
  97. 8.17 Elravie (Humedix)
  98. 8.17.1 Elravie (Humedix) Company Information
  99. 8.17.2 Elravie (Humedix) Business Overview
  100. 8.17.3 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  102. 8.17.5 Elravie (Humedix) Recent Developments
  103. 8.18 Daewoong
  104. 8.18.1 Daewoong Company Information
  105. 8.18.2 Daewoong Business Overview
  106. 8.18.3 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  108. 8.18.5 Daewoong Recent Developments
  109. 8.19 Croma-Pharma
  110. 8.19.1 Croma-Pharma Company Information
  111. 8.19.2 Croma-Pharma Business Overview
  112. 8.19.3 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  114. 8.19.5 Croma-Pharma Recent Developments
  115. 8.20 Cleviel (Pharma Research Products)
  116. 8.20.1 Cleviel (Pharma Research Products) Company Information
  117. 8.20.2 Cleviel (Pharma Research Products) Business Overview
  118. 8.20.3 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  120. 8.20.5 Cleviel (Pharma Research Products) Recent Developments
  121. 8.21 CG Bio
  122. 8.21.1 CG Bio Company Information
  123. 8.21.2 CG Bio Business Overview
  124. 8.21.3 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  126. 8.21.5 CG Bio Recent Developments
  127. 8.22 Caregen
  128. 8.22.1 Caregen Company Information
  129. 8.22.2 Caregen Business Overview
  130. 8.22.3 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  132. 8.22.5 Caregen Recent Developments
  133. 8.23 Bohus BioTech
  134. 8.23.1 Bohus BioTech Company Information
  135. 8.23.2 Bohus BioTech Business Overview
  136. 8.23.3 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  138. 8.23.5 Bohus BioTech Recent Developments
  139. 8.24 Bloomage Bio
  140. 8.24.1 Bloomage Bio Company Information
  141. 8.24.2 Bloomage Bio Business Overview
  142. 8.24.3 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  144. 8.24.5 Bloomage Bio Recent Developments
  145. 8.25 Beijing IMEIK
  146. 8.25.1 Beijing IMEIK Company Information
  147. 8.25.2 Beijing IMEIK Business Overview
  148. 8.25.3 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  150. 8.25.5 Beijing IMEIK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Hyaluronic Acid and Botulinum Toxin Value Chain Analysis
  2. 9.1.1 Injectable Hyaluronic Acid and Botulinum Toxin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process
  6. 9.2 Injectable Hyaluronic Acid and Botulinum Toxin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Hyaluronic Acid and Botulinum Toxin Distributors
  9. 9.2.3 Injectable Hyaluronic Acid and Botulinum Toxin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst